8th Annual Oklahoma Urologic Symposium

 The Symposium will provide a comprehensive and up-to-date review of the most significant advances in urologic care, featuring distinguished faculty from the OU College of Medicine and invited experts. Topics will cover a range of clinical and emerging areas, including the management of recurrent prostate cancer after radiation therapy, new approaches in ablative therapy, and advancements in radiation therapy for localized prostate cancer. Attendees will also engage in a panel discussion on prostate cancer, as well as emerging intravesical therapies for NMIBC, invasive bladder cancer updates, and bladder cancer case reviews. Key presentations will focus on adjuvant therapy for high-risk renal cell carcinoma, the role of surgery in advanced renal cell carcinoma, and novel treatments such as Cretostimogene grenadenorepvec for high-risk BCGu NMIBC.

In the afternoon, the agenda shifts to important updates in clinical practice, including the 2024 AUA OAB guideline and the management of Peyronie’s disease. Perioperative considerations in urethral stricture will also be addressed, followed by a panel discussion on female pelvic cases. Additional topics will feature pediatric urology updates, and a unique session with resident case presentations.

Urologists, Primary Care Physicians, Specialty Physicians, Oncologists, Radiation Oncologists, Related Physician Assistants, Nurses, Nurse Practitioners, Navigators, and other Administrative Staff Supporting Oncology Programs.

• Describe the role of emerging therapies and surgical approaches in the management of prostate cancer recurrence after radiation therapy.
• Identify advancements in the treatment of non-muscle invasive bladder cancer (NMIBC) and their potential impact on clinical practice.
• Apply recent updates in guidelines and treatment strategies for pelvic health, including OAB and Peyronie’s disease, to improve patient outcomes in clinical setting